Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 5.755
Filtrer
1.
J Oleo Sci ; 73(7): 953-961, 2024.
Article de Anglais | MEDLINE | ID: mdl-38945924

RÉSUMÉ

Handwashing represents an important personal hygiene measure for preventing infection. Herein, we report the persistence of antibacterial and antiviral effects after handwashing with fatty acid salt-based hand soap. To this end, we developed a new in vitro test method to measure persistence, utilizing coacervation formed by anionic surfactants and cationic polymers to retain highly effective soap components against each bacterium and virus on the skin. Coacervation with fatty acid salts and poly diallyldimethylammonium chloride (PDADMAC) as a cationic polymer allowed the persistence of antibacterial and antiviral effects against E. coli, S. aureus, and influenza virus even 4 h after handwashing. Furthermore, we confirmed an increase in the number of residual components effective against each bacterium and virus on the skin. In summary, the current findings describe an effective approach for enhancing the protective effects of handwashing.


Sujet(s)
Antibactériens , Antiviraux , Escherichia coli , Désinfection des mains , Polyéthylènes , Composés d'ammonium quaternaire , Peau , Savons , Staphylococcus aureus , Tensioactifs , Savons/pharmacologie , Escherichia coli/effets des médicaments et des substances chimiques , Désinfection des mains/méthodes , Composés d'ammonium quaternaire/pharmacologie , Antibactériens/pharmacologie , Staphylococcus aureus/effets des médicaments et des substances chimiques , Antiviraux/pharmacologie , Peau/effets des médicaments et des substances chimiques , Peau/microbiologie , Tensioactifs/pharmacologie , Humains , Acides gras/pharmacologie , Acides gras/analyse , Facteurs temps , Orthomyxoviridae/effets des médicaments et des substances chimiques
2.
Int J Mol Sci ; 25(11)2024 May 30.
Article de Anglais | MEDLINE | ID: mdl-38892209

RÉSUMÉ

Royal jelly (RJ) is a highly nutritious natural product with great potential for use in medicine, cosmetics, and as a health-promoting food. This bee product is a mixture of important compounds, such as proteins, vitamins, lipids, minerals, hormones, neurotransmitters, flavonoids, and polyphenols, that underlie the remarkable biological and therapeutic activities of RJ. Various bioactive molecules like 10-hydroxy-2-decenoic acid (10-HDA), antibacterial protein, apisin, the major royal jelly proteins, and specific peptides such as apisimin, royalisin, royalactin, apidaecin, defensin-1, and jelleins are characteristic ingredients of RJ. RJ shows numerous physiological and pharmacological properties, including vasodilatory, hypotensive, antihypercholesterolaemic, antidiabetic, immunomodulatory, anti-inflammatory, antioxidant, anti-aging, neuroprotective, antimicrobial, estrogenic, anti-allergic, anti-osteoporotic, and anti-tumor effects. Moreover, RJ may reduce menopause symptoms and improve the health of the reproductive system, liver, and kidneys, and promote wound healing. This article provides an overview of the molecular mechanisms underlying the beneficial effects of RJ in various diseases, aging, and aging-related complications, with special emphasis on the bioactive components of RJ and their health-promoting properties. The data presented should be an incentive for future clinical studies that hopefully will advance our knowledge about the therapeutic potential of RJ and facilitate the development of novel RJ-based therapeutic opportunities for improving human health and well-being.


Sujet(s)
Acides gras , Humains , Acides gras/métabolisme , Acides gras/pharmacologie , Animaux , Anti-inflammatoires/pharmacologie , Anti-inflammatoires/composition chimique , Anti-inflammatoires/usage thérapeutique
3.
Int J Food Microbiol ; 419: 110748, 2024 Jul 16.
Article de Anglais | MEDLINE | ID: mdl-38772217

RÉSUMÉ

An antimicrobial coating was produced by mixing phenolic branched-chain fatty acid (PBC-FA) with glycerol and a carboxymethyl cellulose solution (CMC) at pH 7. The resulting PBC-FA-CMC solution formed an emulsion with an average droplet size of 77 nm. The emulsion in the coating solution was stable for at least 30 days at 20 °C. The in vitro antimicrobial activity of the film formed from the PBC-FA emulsion was tested against a mixture of 3 strains of Listeria innocua (7 log CFU/mL). Film with a concentration of 1000 µg/mL of PBC-FA effectively reduced the population of L. innocua below the limit of detection (<1.48 log CFU/mL) in vitro. The effect of the 1000 µg/mL PBC-FA-CMC coating formulation was then evaluated against L. innocua inoculated on "Gala" apples. Results showed that compared with the non-coated control, the coating reduced L. innocua populations by ~2 log CFU/fruit and ~6 log CFU/fruit on the apple when enumerated on tryptic soy agar and selective media (PALCAM), respectively, indicating that PBC-FA applied as a coating on apples resulted in the sub-lethal injury of bacterial cells. When L. innocua was inoculated onto PBC-FA-coated apples, the L. innocua population decreased by ~4 log CFU/fruit during 14 days of shelf-life at 20 °C. The PBC-FA coating lowered the moisture loss but did not affect the color, firmness, or soluble solids content of apples during the 14-day at 20 °C. Overall, this study revealed that there is a potential that PBC-FA can be used as an antimicrobial coating to inactivate Listeria and preserve the quality of apples.


Sujet(s)
Listeria , Malus , Listeria/effets des médicaments et des substances chimiques , Listeria/croissance et développement , Malus/microbiologie , Fruit/microbiologie , Acides gras/pharmacologie , Conservation aliments/méthodes , Microbiologie alimentaire , Numération de colonies microbiennes , Phénols/pharmacologie
4.
J Nat Prod ; 87(6): 1513-1520, 2024 Jun 28.
Article de Anglais | MEDLINE | ID: mdl-38781491

RÉSUMÉ

Current small-molecule-based SARS-CoV-2 treatments have limited global accessibility and pose the risk of inducing viral resistance. Therefore, a marine algae and cyanobacteria extract library was screened for natural products that could inhibit two well-defined and validated COVID-19 drug targets, disruption of the spike protein/ACE-2 interaction and the main protease (Mpro) of SARS-CoV-2. Following initial screening of 86 extracts, we performed an untargeted metabolomic analysis of 16 cyanobacterial extracts. This approach led to the isolation of an unusual saturated fatty acid, jobosic acid (2,5-dimethyltetradecanoic acid, 1). We confirmed that 1 demonstrated selective inhibitory activity toward both viral targets while retaining some activity against the spike-RBD/ACE-2 interaction of the SARS-CoV-2 omicron variant. To initially explore its structure-activity relationship (SAR), the methyl and benzyl ester derivatives of 1 were semisynthetically accessed and demonstrated acute loss of bioactivity in both SARS-CoV-2 biochemical assays. Our efforts have provided copious amounts of a fatty acid natural product that warrants further investigation in terms of SAR, unambiguous determination of its absolute configuration, and understanding of its specific mechanisms of action and binding site toward new therapeutic avenues for SARS-CoV-2 drug development.


Sujet(s)
Antiviraux , Métabolomique , SARS-CoV-2 , SARS-CoV-2/effets des médicaments et des substances chimiques , Antiviraux/pharmacologie , Antiviraux/composition chimique , Antiviraux/isolement et purification , Humains , Cyanobactéries/composition chimique , Relation structure-activité , Acides gras/composition chimique , Acides gras/pharmacologie , COVID-19 , Structure moléculaire , Protéases 3C des coronavirus/antagonistes et inhibiteurs , Protéases 3C des coronavirus/métabolisme
5.
J Nat Prod ; 87(6): 1652-1659, 2024 Jun 28.
Article de Anglais | MEDLINE | ID: mdl-38787359

RÉSUMÉ

Phytochemical investigation of the fruit and flowers of Passiflora foetida led to the isolation of 14 compounds, of which five are previously undescribed fatty acid lactones. Four 2-pyrones, passifetilactones A-D (1-4), and one furanone, passifetilactone E (5), were identified by analysis of spectroscopic and spectrometric data. The previously undescribed lactones were tested for cytotoxic activities against the cancer cell lines HeLa, A549, PC-3, KKU-055, and KKU-213A and two normal cell lines, Vero and MMNK-1. Passifetilactones B (2) and C (3) displayed good to mild cytotoxic activity, at IC50 3.7-25.9 µM and 12.2-19.8 µM, respectively, against six cell lines, but were weakly active against the MMNK-1 cell line. Passifetilactones B and C (2 and 3) showed cell apoptosis induction on the KKU-055 cell line in a flow cytometry experiment. Passifetilactone D (4) is an isolation artifact produced by purification over silica gel, but we demonstrated that it can also be slowly formed within the crude EtOAc extract. This is the first investigation of the flowers and the fruit of this plant.


Sujet(s)
Antinéoplasiques d'origine végétale , Fleurs , Fruit , Lactones , Passiflora , Fleurs/composition chimique , Humains , Fruit/composition chimique , Lactones/composition chimique , Lactones/pharmacologie , Lactones/isolement et purification , Passiflora/composition chimique , Antinéoplasiques d'origine végétale/pharmacologie , Antinéoplasiques d'origine végétale/composition chimique , Antinéoplasiques d'origine végétale/isolement et purification , Structure moléculaire , Animaux , Acides gras/composition chimique , Acides gras/pharmacologie , Acides gras/isolement et purification , Apoptose/effets des médicaments et des substances chimiques , Tests de criblage d'agents antitumoraux , Lignée cellulaire tumorale , Cellules HeLa , Chlorocebus aethiops , Cellules Vero
6.
Viruses ; 16(5)2024 05 11.
Article de Anglais | MEDLINE | ID: mdl-38793641

RÉSUMÉ

Acinetobacter baumannii has developed multiple drug resistances, posing a significant threat to antibiotic efficacy. LysECD7, an endolysin derived from phages, could be a promising therapeutic agent against multi-drug resistance A. baumannii. In this study, in order to further enhance the antibacterial efficiency of the engineered LysECD7, a few lipopolysaccharide-interacting peptides (Li5, MSI594 and Li5-MSI) were genetically fused with LysECD7. Based on in vitro antibacterial activity, the fusion protein Lys-Li5-MSI was selected for further modifications aimed at extending its half-life. A cysteine residue was introduced into Lys-Li5-MSI through mutation (Lys-Li5-MSIV12C), followed by conjugation with a C16 fatty acid chain via a protonation substitution reaction(V12C-C16). The pharmacokinetic profile of V12C-C16 exhibited a more favorable characteristic in comparison to Lys-Li5-MSI, thereby resulting in enhanced therapeutic efficacy against lethal A. baumannii infection in mice. The study provides valuable insights for the development of novel endolysin therapeutics and proposes an alternative therapeutic strategy for combating A. baumannii infections.


Sujet(s)
Infections à Acinetobacter , Acinetobacter baumannii , Antibactériens , Endopeptidases , Lipopolysaccharides , Acinetobacter baumannii/effets des médicaments et des substances chimiques , Animaux , Endopeptidases/pharmacologie , Endopeptidases/métabolisme , Endopeptidases/composition chimique , Endopeptidases/génétique , Souris , Infections à Acinetobacter/traitement médicamenteux , Infections à Acinetobacter/microbiologie , Antibactériens/pharmacologie , Antibactériens/composition chimique , Lipopolysaccharides/métabolisme , Acides gras/métabolisme , Acides gras/composition chimique , Acides gras/pharmacologie , Tests de sensibilité microbienne , Peptides/pharmacologie , Peptides/composition chimique , Protéines de fusion recombinantes/pharmacologie , Protéines de fusion recombinantes/génétique , Protéines de fusion recombinantes/composition chimique , Femelle , Souris de lignée BALB C , Modèles animaux de maladie humaine
7.
J Ethnopharmacol ; 331: 118323, 2024 Sep 15.
Article de Anglais | MEDLINE | ID: mdl-38729535

RÉSUMÉ

ETHNOPHARMACOLOGICAL RELEVANCE: India's ancient texts, the Charak Samhita and Sushruta Samhita, make reference to the traditional medicinal usage of Acorus calamus L. In India and China, it has long been used to cure stomach aches, cuts, diarrhea, and skin conditions. This ability of the rhizome is attributed to its antimicrobial properties. Research studies to date have shown its antimicrobial properties. However, scientific evidence on its mode of action is still lacking. AIM OF THE STUDY: Acorus calamus L. rhizome extract and its bioactive fraction exhibits antibacterial effect by modulating membrane permeability and fatty acid composition. MATERIAL AND METHOD: The secondary metabolites in the rhizome of A. calamus L. were extracted in hexane using Soxhlet apparatus. The ability of the extract to inhibit multidrug resistant bacterial isolates, namely Bacillus cereus, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa were evaluated using checkerboard assay. Further, the extract was purified using thin layer chromatography, gravity column chromatography, and combiflash chromatography. Structure elucidation of the active compound was done using GC-MS, FT-IR, and UV-Vis spectral scan. The mode of action of the bioactive fraction was determined. Bacterial membrane damage was analyzed using SEM, membrane permeability was determined using SYBR green I and PI dye, leakage of cytoplasmic contents were analyzed using Bradford assay and Fehling's reagent. The ability to inhibit efflux pump of A. baumannii was determined using EtBr accumulation assay and ß-lactamase inhibition was analyzed using nitrocefin as substrate. Also, the biofilm inhibition of B. cereus was determined using crystal violet dye. Moreover, the effect of the bioactive fraction on the fatty acid profile of the bacterial membrane was determined by GC-FAME analysis using 37 component FAME mix as standard. RESULTS: Acorus calamus L. rhizome hexane extract (AC-R-H) demonstrated broad-spectrum antibacterial activity against all the isolates tested. AC-R-H extract also significantly reduced the MIC of ampicillin against all tested bacteria, indicating its bacterial resistance modulating properties. The assay guided purification determined Asarone as the major compound present in the bioactive fraction (S-III-BAF). S-III-BAF was found to reduce the MIC of ampicillin against Escherichia coli (100-25 mg/mL), Pseudomonas aeruginosa (15-3.25 mg/mL), Acinetobacter baumannii (12.5-1.56 mg/ml), and Bacillus cereus (10-1.25 mg/mL). Further, it recorded synergistic activity with ampicillin against B. cereus (FICI = 0.365), P. aeruginosa (FICI = 0.456), and A. baumannii (FICI = 0.245). The mode of action of S-III-BAF can be attributed to its ability to disturb the membrane integrity, enhance membrane permeability, reduce biofilm formation, and possibly alter the fatty acid composition of the bacterial cell membranes. CONCLUSION: The bioactive fraction of AC-R-H extract containing Asarone as the active compound showed antibacterial activity and synergistic interactions with ampicillin against the tested bacterial isolates. Such activity can be attributed to the modulation of fatty acids present in bacterial membranes, which enhances membrane permeability and causes membrane damage.


Sujet(s)
Acorus , Antibactériens , Perméabilité des membranes cellulaires , Acides gras , Tests de sensibilité microbienne , Extraits de plantes , Rhizome , Antibactériens/pharmacologie , Antibactériens/isolement et purification , Antibactériens/composition chimique , Rhizome/composition chimique , Acorus/composition chimique , Extraits de plantes/pharmacologie , Extraits de plantes/composition chimique , Perméabilité des membranes cellulaires/effets des médicaments et des substances chimiques , Acides gras/pharmacologie , Acides gras/composition chimique , Dérivés de l'allylbenzène , Anisoles/pharmacologie , Anisoles/isolement et purification , Anisoles/composition chimique
8.
Biofouling ; 40(3-4): 235-244, 2024.
Article de Anglais | MEDLINE | ID: mdl-38584359

RÉSUMÉ

The association between dysbiotic microbiota biofilm and colon cancer has recently begun to attract attention. In the study, the apitherapeutic effects of bee products (honey, bee venom, royal jelly, pollen, perga and propolis) obtained from the endemic Yigilca ecotype of Apis mellifera anatoliaca were investigated. Antibiofilm activity were performed by microplate assay using crystal violet staining to measure adherent biofilm biomass of Escherichia coli capable of forming biofilms. Bee venom showed the highest inhibition effect (73.98%) at 50% concentration. Honey, perga and royal jelly reduced biofilm formation by >50% at all concentrations. The antiproliferation effect on the HCT116 colon cancer cell line was investigated with the water­soluble tetrazolium salt­1 assay. After 48 h of honey application at 50% concentration, cell proliferation decreased by 86.51%. The high cytotoxic effects of royal jelly and bee venom are also remarkable. Additionally, apoptotic pathway analysis was performed by ELISA using caspase 3, 8 and 9 enzyme-linked immunosorbent assay kits. All bee products induced a higher expression of caspase 9 compared with caspase 8. Natural products that upregulate caspase proteins are promising therapeutic targets for proliferative diseases.


Sujet(s)
Antinéoplasiques , Venins d'abeille , Biofilms , Tumeurs du côlon , Escherichia coli , Acides gras , Propolis , Biofilms/effets des médicaments et des substances chimiques , Humains , Animaux , Venins d'abeille/pharmacologie , Escherichia coli/effets des médicaments et des substances chimiques , Escherichia coli/physiologie , Tumeurs du côlon/traitement médicamenteux , Abeilles/effets des médicaments et des substances chimiques , Cellules HCT116 , Propolis/pharmacologie , Propolis/composition chimique , Acides gras/pharmacologie , Antinéoplasiques/pharmacologie , Miel , Prolifération cellulaire/effets des médicaments et des substances chimiques , Pollen/composition chimique , Antibactériens/pharmacologie , Apoptose/effets des médicaments et des substances chimiques
9.
J Cell Biochem ; 125(6): e30571, 2024 06.
Article de Anglais | MEDLINE | ID: mdl-38666486

RÉSUMÉ

Medium-chain fatty acids (MCFAs) have 6-12 carbon atoms and are instantly absorbed into the bloodstream before traveling to the portal vein and the liver, where they are immediately used for energy and may have antitumor effects. Its role in breast cancer is poorly understood. To investigate the apoptosis-inducing effect of MCFAs in breast cancer cells, cell viability assay, colony formation assay, cell migration assay, cell invasion assay, nuclear morphology, cell cycle assay, intracellular reactive oxygen species (ROS), matrix metalloproteinase (MMP), apoptosis, RT-qPCR analysis, and Western blot analysis were performed. In the present study, MCFA treatments reduced proliferative capability, increased ROS level, increased the depletion of MMP, induced G0/G1 and S phase cell cycle arrest, and late apoptosis of breast cancer cells in an effective concentration. Besides, MCFA treatment contributed to the upregulation of proapoptotic protein (BAK) and caspase-3, and the downregulation of antiapoptotic protein (Bcl-2). Mechanistically, phosphorylation levels of EGFR, Akt, and mTOR were significantly reduced in breast cancer cells treated with MCFAs. However, no significant changes in apoptosis and signaling-related proteins were observed in lauric acid-treated ER-positive cancer cells. Our findings suggested that MCFAs suppressed breast cancer cell proliferation by modulating the PI3K/Akt/mTOR signaling pathway. MCFAs may be a promising therapeutic drug for treating breast cancer.


Sujet(s)
Apoptose , Tumeurs du sein , Prolifération cellulaire , Acides gras , Protéines proto-oncogènes c-bcl-2 , Transduction du signal , Femelle , Humains , Apoptose/effets des médicaments et des substances chimiques , Tumeurs du sein/métabolisme , Tumeurs du sein/traitement médicamenteux , Tumeurs du sein/anatomopathologie , Lignée cellulaire tumorale , Mouvement cellulaire/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Acides gras/métabolisme , Acides gras/pharmacologie , Régulation de l'expression des gènes tumoraux/effets des médicaments et des substances chimiques , Cellules MCF-7 , Protéines proto-oncogènes c-akt/métabolisme , Protéines proto-oncogènes c-bcl-2/métabolisme , Espèces réactives de l'oxygène/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , Sérine-thréonine kinases TOR/métabolisme
10.
Molecules ; 29(8)2024 Apr 11.
Article de Anglais | MEDLINE | ID: mdl-38675558

RÉSUMÉ

The cannabinoid-type I (CB1) receptor functions as a double-edged sword to decide cell fate: apoptosis/survival. Elevated CB1 receptor expression is shown to cause acute ceramide accumulation to meet the energy requirements of fast-growing cancers. However, the flip side of continual CB1 activation is the initiation of a second ceramide peak that leads to cell death. In this study, we used ovarian cancer cells, PA1, which expressed CB1, which increased threefold when treated with a natural compound, bis(palmitoleic acid) ester of a glycerol (C2). This novel compound is isolated from a marine snail, Conus inscriptus, using hexane and the structural details are available in the public domain PubChem database (ID: 14275348). The compound induced two acute ceramide pools to cause G0/G1 arrest and killed cells by apoptosis. The compound increased intracellular ceramides (C:16 to 7 times and C:18 to 10 times), both of which are apoptotic inducers in response to CB1 signaling and thus the compound is a potent CB1 agonist. The compound is not genotoxic because it did not induce micronuclei formation in non-cancerous Chinese hamster ovarian (CHO) cells. Since the compound induced the cannabinoid pathway, we tested if there was a psychotropic effect in zebrafish models, however, it was evident that there were no observable neurobehavioral changes in the treatment groups. With the available data, we propose that this marine compound is safe to be used in non-cancerous cells as well as zebrafish. Thus, this anticancer compound is non-toxic and triggers the CB1 pathway without causing psychotropic effects.


Sujet(s)
Apoptose , Céramides , Conus , Acides gras , Récepteur cannabinoïde de type CB1 , Animaux , Femelle , Humains , Apoptose/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale , Céramides/métabolisme , Céramides/composition chimique , Acides gras/pharmacologie , Acides gras/composition chimique , Acides gras/métabolisme , Récepteur cannabinoïde de type CB1/métabolisme , Récepteur cannabinoïde de type CB1/génétique , Transduction du signal/effets des médicaments et des substances chimiques , Conus/composition chimique
11.
Mar Drugs ; 22(4)2024 Mar 28.
Article de Anglais | MEDLINE | ID: mdl-38667770

RÉSUMÉ

Shrimp processing generates substantial waste, which is rich in valuable components such as polysaccharides, proteins, carotenoids, and fatty acids. This review provides a comprehensive overview of the valorization of shrimp waste, mainly shrimp shells, focusing on extraction methods, bioactivities, and potential applications of these bioactive compounds. Various extraction techniques, including chemical extraction, microbial fermentation, enzyme-assisted extraction, microwave-assisted extraction, ultrasound-assisted extraction, and pressurized techniques are discussed, highlighting their efficacy in isolating polysaccharides, proteins, carotenoids, and fatty acids from shrimp waste. Additionally, the bioactivities associated with these compounds, such as antioxidant, antimicrobial, anti-inflammatory, and antitumor properties, among others, are elucidated, underscoring their potential in pharmaceutical, nutraceutical, and cosmeceutical applications. Furthermore, the review explores current and potential utilization avenues for these bioactive compounds, emphasizing the importance of sustainable resource management and circular economy principles in maximizing the value of shrimp waste. Overall, this review paper aims to provide insights into the multifaceted aspects of shrimp waste valorization, offering valuable information for researchers, industries, and policymakers interested in sustainable resource utilization and waste-management strategies.


Sujet(s)
Penaeidae , Gestion des déchets , Animaux , Antioxydants/pharmacologie , Antioxydants/isolement et purification , Antioxydants/composition chimique , Caroténoïdes/pharmacologie , Caroténoïdes/isolement et purification , Caroténoïdes/composition chimique , Acides gras/isolement et purification , Acides gras/composition chimique , Acides gras/pharmacologie , Penaeidae/composition chimique , Polyosides/pharmacologie , Polyosides/isolement et purification , Polyosides/composition chimique , Protéines/isolement et purification , Gestion des déchets/méthodes , Déchets
12.
Sci Rep ; 14(1): 6532, 2024 03 19.
Article de Anglais | MEDLINE | ID: mdl-38503788

RÉSUMÉ

The increasing antimicrobial resistance requires continuous investigation of new antimicrobial agents preferably derived from natural sources. New powerful antibacterial agents can be produced by simply combining oils that are known for their antibacterial activities. In this study, apricot seed oil (ASO), date seed oil (DSO), grape seed oil (GSO), and black seed oil (BSO) alone and in binary mixtures were assessed. Fatty acid profiles of individual oils and oil mixtures showed linoleic acid, oleic acid, palmitic acid, stearic acid, and linolenic acid contents. Linoleic acid was the most abundant fatty acid in all samples except for ASO, where oleic acid was the dominant one. GSO showed the highest total phenolic content while ASO showed the lowest one. Antibacterial screening was performed against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, and Staphylococcus aureus. Results showed antibacterial activity in all oils against tested strains except for ASO against S. aureus. Highest antibacterial activity recorded was for ASO against P. mirabilis. ASO-GSO mixture (AG) was the best mixture where it showed synergistic interactions against all strains except P. aeruginosa. In conclusion, seed oil mixtures are likely to show promising antibacterial activities against specific strains.


Sujet(s)
Prunus armeniaca , Vitis , Acide linoléique , Staphylococcus aureus , Acides gras/pharmacologie , Huiles végétales/pharmacologie , Acide oléique/pharmacologie , Antibactériens/pharmacologie , Graines
13.
Adv Nutr ; 15(4): 100196, 2024 04.
Article de Anglais | MEDLINE | ID: mdl-38432590

RÉSUMÉ

Cannabis use has increased sharply in the last 20 y among adults, including reproductive-aged women. Its recent widespread legalization is associated with a decrease in risk perception of cannabis use during breastfeeding. However, the effect of cannabis use (if any) on milk production and milk composition is not known. This narrative review summarizes current knowledge related to maternal cannabis use during breastfeeding and provides an overview of possible pathways whereby cannabis might affect milk composition and production. Several studies have demonstrated that cannabinoids and their metabolites are detectable in human milk produced by mothers who use cannabis. Due to their physicochemical properties, cannabinoids are stored in adipose tissue, can easily reach the mammary gland, and can be secreted in milk. Moreover, cannabinoid receptors are present in adipocytes and mammary epithelial cells. The activation of these receptors directly modulates fatty acid metabolism, potentially causing changes in milk fatty acid profiles. Additionally, the endocannabinoid system is intimately connected to the endocrine system. As such, it is probable that interactions of exogenous cannabinoids with the endocannabinoid system might modify release of critical hormones (e.g., prolactin and dopamine) that regulate milk production and secretion. Nonetheless, few studies have investigated effects of cannabis use (including on milk production and composition) in lactating women. Additional research utilizing robust methodologies are needed to elucidate whether and how cannabis use affects human milk production and composition.


Sujet(s)
Cannabinoïdes , Cannabis , Adulte , Femelle , Humains , Animaux , Lactation , Lait humain/composition chimique , Allaitement naturel , Endocannabinoïdes/analyse , Endocannabinoïdes/métabolisme , Endocannabinoïdes/pharmacologie , Lait/composition chimique , Cannabinoïdes/pharmacologie , Cannabinoïdes/analyse , Cannabinoïdes/métabolisme , Acides gras/pharmacologie
14.
J Appl Microbiol ; 135(3)2024 Mar 01.
Article de Anglais | MEDLINE | ID: mdl-38449343

RÉSUMÉ

AIMS: This study aimed to investigate the changes of cell membrane structure and function of Issatchenkia terricola under citric acid by performing physiological analysis. METHODS AND RESULTS: The membrane integrity, surface hydrophobicity, structure, fluidity, apoptosis, and fatty acid methyl esters composition of I. terricola WJL-G4 cells were determined by propidium iodide staining, microbial adhesion to hydrocarbon test, transmission electron microscopy analysis, fluorescence anisotropy, flow cytometry, and gas chromatography-mass, respectively. The results showed that with the increasing of citric acid concentrations, the cell vitality, membrane integrity, and fluidity of I. terricola reduced; meanwhile, apoptosis rate, membrane permeable, hydrophobicity, and ergosterol contents augmented significantly. Compared to control, the activities of Na+, K+-ATPase, and Ca2+, Mg2+-ATPase increased by 3.73-fold and 6.70-fold, respectively, when citric acid concentration increased to 20 g l-1. The cells cracked and their cytoplasm effused when the citric acid concentration reached 80 g l-1. CONCLUSIONS: I. terricola could successfully adjust its membrane structure and function below 60 g l-1 of citric acid. However, for citric acid concentrations above 80 g l-1, its structure and function were dramatically changed, which might result in reduced functionality.


Sujet(s)
Structures de la membrane cellulaire , Acide citrique , Pichia , Acide citrique/pharmacologie , Acides gras/pharmacologie , Membrane cellulaire , Fluidité membranaire
15.
J Med Entomol ; 61(3): 701-709, 2024 May 13.
Article de Anglais | MEDLINE | ID: mdl-38460150

RÉSUMÉ

Insecticide resistance in mosquito populations has long been recognized as a significant global public health challenge, motivating the development of new control chemistries. ReMoa Tri is a novel triple-action space spray that employs a different mode of action than traditional adult mosquito control formulations. It combines 3 components: fenpropathrin, a mixed-type I/II pyrethroid; abamectin, a macrocyclic lactone; and C8910, a patented fatty acid chain. As an ultra-low volume adulticide, ReMoa Tri has the potential to target mosquito species that are resistant to pyrethroid and organophosphate-based control materials. To determine whether ReMoa Tri effectively targets resistant mosquito species in Florida's Collier County, United States, we conducted ground-based field cage trials using field-caught pyrethroid-resistant Culex quinquefasciatus (Say) and Aedes aegypti (L.), of which the latter also displayed developing resistance to organophosphates. Trials were also conducted against the same mosquito populations with Merus 3.0, a pyrethrin-based adulticide used by the Collier Mosquito Control District. ReMoa Tri was effective against Collier's pyrethroid-resistant Cx. quinquefasciatus, resulting in more than 95% mortality in semifield cage trials by 24 h postapplication. Similarly, ReMoa Tri applications against Collier's pyrethroid-resistant Ae. aegypti resulted in 72%-89% mortality at 24 h postapplication and 74%-97% mortality at 48 h postapplication. This study represents the first field data on this novel space spray, and its findings shed light on the performance of ReMoa Tri against local mosquito populations that have developed resistance to currently available adulticides.


Sujet(s)
Aedes , Culex , Résistance aux insecticides , Insecticides , Lutte contre les moustiques , Pyréthrines , Animaux , Aedes/effets des médicaments et des substances chimiques , Insecticides/pharmacologie , Pyréthrines/pharmacologie , Culex/effets des médicaments et des substances chimiques , Acides gras/pharmacologie , Femelle , Lactones/pharmacologie
16.
Nutrients ; 16(6)2024 Mar 15.
Article de Anglais | MEDLINE | ID: mdl-38542756

RÉSUMÉ

Obesity is a global health concern. Recent research has suggested that the development of anti-obesity ingredients and functional foods should focus on natural products without side effects. We examined the effectiveness and underlying mechanisms of Brassica juncea extract (BJE) in combating obesity via experiments conducted in both in vitro and in vivo obesity models. In in vitro experiments conducted in a controlled environment, the application of BJE demonstrated the ability to suppress the accumulation of lipids induced by MDI in 3T3-L1 adipocytes. Additionally, it downregulated adipogenic-related proteins peroxisome proliferator-activated receptor-γ (PPAR-γ), CCAAT/enhancer-binding protein-α (C/EBP-α), adipocyte protein 2 (aP2), and lipid synthesis-related protein acetyl-CoA carboxylase (ACC). It also upregulated the heat generation protein peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α) and fatty acid oxidation protein carnitine palmitoyltransferase-1 (CPT-1). The oral administration of BJE decreased body weight, alleviated liver damage, and inhibited the accumulation of lipids in mice with diet-induced obesity resulting from a high-fat diet. The inhibition of lipid accumulation by BJE in vivo was associated with a decreased expression of adipogenic and lipid synthesis proteins and an increased expression of heat generation and fatty acid oxidation proteins. BJE administration improved obesity by decreasing adipogenesis and activating heat generation and fatty acid oxidation in 3T3-L1 cells and in HFD-induced obese C57BL/6J mice. These results suggest that BJE shows potential as a natural method for preventing metabolic diseases associated with obesity.


Sujet(s)
Agents antiobésité , Moutarde (plante) , Souris , Animaux , Cellules 3T3-L1 , Moutarde (plante)/métabolisme , Alimentation riche en graisse/effets indésirables , Souris de lignée C57BL , Souris obèse , Agents antiobésité/usage thérapeutique , Obésité/métabolisme , Adipogenèse , Lipides/pharmacologie , Acides gras/pharmacologie , Récepteur PPAR gamma/métabolisme
17.
Biomed Res ; 45(1): 33-43, 2024.
Article de Anglais | MEDLINE | ID: mdl-38325844

RÉSUMÉ

Fish oil (FO) is rich in the n-3 polyunsaturated fatty acids. It has been demonstrated that FO intake possesses lipid-lowering properties. Conversely, a high-cholesterol (CH) diet promotes lipid accumulation in the liver and induces fatty liver. This study investigated the effects of FO feeding on hepatic lipid accumulation induced by high-cholesterol feeding in KK mice. All experimental diets had a fat energy ratio of 25%, the SO group had all fat sources as safflower oil (SO), the 12.5 FO group had half of the SO replaced with FO, and the 25 FO group had all of the SO replaced with FO, each with or without 2 weight % (wt%) cholesterol (SO/CH, 12.5 FO/CH, and 25 FO/CH groups, respectively), for 8 weeks. The hepatic triglyceride and total cholesterol levels were significantly lower in the 25 FO/CH group than in the SO/CH group. The hepatic mRNAs of fatty acid synthesis-related genes were downregulated by the FO feeding groups. In view of importance to establish the benefit of FO for preventing severe NAFLD, our results suggest that FO intake prevents excessive hepatic fat accumulation induced by a high-cholesterol diet in obese KK mice through the inhibition of fatty acid synthesis.


Sujet(s)
Huiles de poisson , Métabolisme lipidique , Souris , Animaux , Huiles de poisson/pharmacologie , Huiles de poisson/métabolisme , Foie/métabolisme , Cholestérol/métabolisme , Cholestérol/pharmacologie , Acides gras/métabolisme , Acides gras/pharmacologie , Obésité/étiologie , Obésité/prévention et contrôle , Obésité/métabolisme
18.
Analyst ; 149(6): 1872-1884, 2024 Mar 11.
Article de Anglais | MEDLINE | ID: mdl-38349213

RÉSUMÉ

Neuroblastoma and glioblastoma are the most commonly seen nervous system tumors, and their treatment is challenging. Relatively safe and easy acquisition of nutraceutical natural products make them suitable candidates for anticancer research. Royal jelly (RJ), a superfood, has many biological and pharmacological activities. This study was conducted to, for the first time, elucidate its anticancer efficiency, even in high doses, on neuroblastoma and glioblastoma cell lines through cell viability, apoptosis, cell cycle and biomolecular content evaluation. We performed experiments with RJ concentrations in the range of 1.25-10 mg mL-1 for 48 h. Cell viability assays revealed a notable cytotoxic effect of RJ in a concentration-dependent manner. Treatment with a high dose of RJ significantly increased the apoptotic cell population of both cell lines. Furthermore, we observed G0-G1 phase arrest in neuroblastoma cells but G2-M arrest in glioblastoma cells. All these cellular changes are closely associated with the alterations of the macromolecular makeup of the cells, such as decreased saturated lipid, protein, DNA and RNA amounts, protein conformational changes, decreased protein phosphorylation and increased protein carbonylation. These cellular changes are associated with RJ triggered-ROS formation. The clear segregation between the control and the RJ-treated groups proved these changes, obtained from the unsupervised and supervised chemometric analysis. RJ has good anticancer activity against nervous system cancers and could be safely used with current treatment strategies.


Sujet(s)
Glioblastome , Neuroblastome , Humains , Apoptose , Glioblastome/traitement médicamenteux , Lignée cellulaire tumorale , Points de contrôle de la phase G2 du cycle cellulaire , Acides gras/pharmacologie , Prolifération cellulaire , Neuroblastome/traitement médicamenteux
19.
Vet Q ; 44(1): 1-11, 2024 Dec.
Article de Anglais | MEDLINE | ID: mdl-38404134

RÉSUMÉ

Chinese herbal formula (CHF) has the potential to improve the performance of aged laying hens through integrated regulation of various physiological functions. The present study aimed to investigate the effects of dietary CHF supplementation on the yolk fatty acid profile in aged laying hens. A total of 144 healthy 307-day-old Xinyang black-feather laying hens were randomly allocated into two groups: a control group (CON, fed a basal diet) and a CHF group (fed a basal diet supplemented with 1% CHF; contained 0.30% Leonurus japonicus Houtt., 0.20% Salvia miltiorrhiza Bge., 0.25% Ligustrum lucidum Ait., and 0.25% Taraxacum mongolicum Hand.-Mazz. for 120 days). The fatty acid concentrations in egg yolks were analyzed using a targeted metabolomics technology at days 60 and 120 of the trial. The results showed that dietary CHF supplementation increased (p < .05) the concentrations of several saturated fatty acids (SFA, including myristic acid and stearic acid), monounsaturated fatty acids (MUFA, including petroselinic acid, elaidic acid, trans-11-eicosenoic acid, and cis-11-eicosenoic acid), polyunsaturated fatty acids (PUFA, including linolelaidic acid, linoleic acid, γ-linolenic acid, α-linolenic acid, 11c,14c-eicosadienoic acid, eicosatrienoic acid, homo-γ-linolenic acid, arachidonic acid, and docosapentaenoic acid), and fatty acid indexes (total MUFA, n-3 and n-6 PUFA, PUFA/SFA, hypocholesterolemic/hypercholesterolaemic ratio, health promotion index, and desirable fatty acids) in egg yolks. Collectively, these findings suggest that dietary CHF supplementation could improve the nutritional value of fatty acids in egg yolks of aged laying hens, which would be beneficial for the production of healthier eggs to meet consumer demands.


Sujet(s)
Poulets , Acides gras , Animaux , Femelle , Acides gras/pharmacologie , Poulets/physiologie , Compléments alimentaires , Régime alimentaire/médecine vétérinaire , Jaune d'œuf , Acide linoléique/pharmacologie , Aliment pour animaux/analyse
20.
Burns ; 50(4): 924-935, 2024 05.
Article de Anglais | MEDLINE | ID: mdl-38378390

RÉSUMÉ

Wound healing is a physiological process that results in the reconstruction and restoration of granulation tissue, followed by scar formation. We explored the impact of fatty acids in the form of oils on wound healing since they are part of membrane phospholipids and participate in the inflammatory response. This work investigated the efficiency of fatty acids extracted from microalga Parachlorella kessleri in treating excisional wounds and burns and evaluated their antioxidant activity. The rationale behind this investigation lies in the integral role fatty acids play in membrane phospholipids and their involvement in the inflammatory response. Among different nitrogen sources, glycine showed the highest biomass and lipid productivity (0.08 g L-1 d-1 and 58.37 µgml-1 day-1, respectively). Based on the percentage of polyunsaturated fatty acids that increased by 50.38 % in the Glycine culture of P. kessleri, both total antioxidant capacity and DPPH radical scavenging activity were higher in the Glycine culture than control culture. In 30 anaesthetized male mice divided into 6 groups, using either a burn or an excision, two identical paravertebral full-thickness skin lesions were created. Either oils of P. kessleri (extracted from control and glycine culture) ointments or the vehicle (placebo cream) were applied twice daily to the excisional wounds of mice, while mebo cream was used for burn wounds as well as P. kessleri oil. P. kessleri oils (control or glycine culture) showed a significant effect on the reduction of excisional wounds and burns. Histopathological analysis showed that angiogenesis, collagen fiber formation, and epidermis creation were some of the healing indicators that improved. The key elements for this healing property are omega -3 fatty acids, and both P. kessleri oils extracted from control and glycine culture have significant wound-healing effects. Oil of glycine culture of P. kessleri, however, displayed superior results in this regard.


Sujet(s)
Antioxydants , Brûlures , Microalgues , Cicatrisation de plaie , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Animaux , Souris , Brûlures/traitement médicamenteux , Brûlures/anatomopathologie , Antioxydants/pharmacologie , Antioxydants/usage thérapeutique , Mâle , Acides gras/pharmacologie , Glycine/pharmacologie , Glycine/usage thérapeutique , Chlorophyta , Peau/traumatismes , Peau/effets des médicaments et des substances chimiques
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE